BCAC and Lung Foundation NZ media release, 3 May...
BCAC and Lung Foundation NZ media release, 30 April 2019
Health advocacy groups and individuals will present strongly worded petitions to Parliament on 7 May demanding proper funding of medicines.
Breast Cancer Aotearoa Coalition media release, 23 April 2019: PHARMAC has refused funding for Kadcyla, an important drug that has recently had a high media and public profile.
Media release: A powerful group of women will be speaking at the Health Select Committee on 13 and 20 March to describe how traumatic it is for them to know that medicines that would give them longer lives aren’t...
Breast Cancer Aotearoa Coalition media release, 16 October 2018
Women marching to Parliament today, to present two petitions calling for Government funding of vital medicines, have 100% support from a coalition representing more than 30 breast cancer organisations.
Breast Cancer Aotearoa Coalition media release, 7 September 2018
New Zealand needs to stop treating people with advanced breast cancer as second class citizens, Breast Cancer Aotearoa Coalition (BCAC) says.
The coalition of more than 30 breast cancer-related group says a report out today by the Breast Cancer Foundation of New Zealand (BCFNZ) reveals the shockingly high mortality rates for New Zealand women compared to other comparable countries.
The Government must increase funding for medicines desperately needed by people with breast cancer and other cancers, Breast Cancer Aotearoa Coalition (BCAC) says.
A breast cancer charity says a new report that identifies a multi-million dollar funding gap for medicines is a damning indictment of a failing system and an urgent wake-up call for change.
The report by the New Zealand Institute of Economic Research (NZIER) has found that medicines funding has fallen in real terms every year since 2007 to the point where there is now an investment gap of more than $680 million.
The Breast Cancer Aotearoa Coalition (BCAC) is thrilled to see a proposed extension of the upper age for free breast screening from 69 to 74-years-old in the Labour-New Zealand First coalition agreement.
The move is one of the key details for health outlined in the coalition agreement. At the moment, BreastScreen Aotearoa only offers free breast screening to women between the ages of 45 and 69.
A breakthrough breast cancer drug can now be used in New Zealand, but the Breast Cancer Aotearoa Coalition (BCAC) is calling for Ibrance (palbociclib) to be publicly funded immediately.
MedSafe NZ has just approved the use of Ibrance for those with advanced hormone receptor positive and HER2-negative breast cancer, but it’s only available to those who can pay for it.
On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.